The 4.4 Problem: Why an Entire Industry Is Mediocre at AI Visibility

We have now run 36 AI visibility assessments across 30 healthcare organizations. The single most important number to come out of that work is not dramatic. It is an average. 4.4 out of 10.

That is the mean AI readiness score across the entire dataset, from the number one-ranked cancer center in the country to three-location specialty practices. The number is low, but the low number is not the real story. The real story is how little it moves. Whether an organization is a nationally ranked academic system or a community hospital, the score lands in roughly the same place. An entire industry is sitting at a 4.4, and most of it does not know.

Key Takeaways

• Mean AI readiness across 36 assessments of 30 organizations is 4.4 out of 10, and scores cluster tightly at the low end regardless of size, funding, or clinical ranking.
• The defining feature of the data is low variance. Market leaders are not meaningfully ahead of small practices, which means no one in the field has built a durable advantage yet.
• Uniform mediocrity is not a stable equilibrium. It is an open field, and the first organizations to do the structural work can quickly separate from the pack.
• Benchmarking against peers is misleading when the entire peer set is underperforming. The honest benchmark is absolute: how often does AI cite you when a patient is actually looking?
• Closing the gap is structural work, not a bigger budget, which is exactly why the opportunity is still available.

What does a 4.4 actually mean?

AI readiness, the way we score it, measures how reliably an organization shows up when a patient uses an AI engine to navigate care. It is built from five dimensions: answer engine optimization, content authority, the digital front door, data integration, and AI governance. A 10 would mean an organization is consistently the answer when patients in its market ask about the conditions it treats. A 4.4 means it shows up less than half the time, and often far less than that on the generic, non-branded queries that bring in new patients.

Put in plainer terms, a 4.4 organization is invisible in most of the AI searches that matter for its growth. The patient asks a question, gets a short answer naming a few options, and that organization is usually not among them. The patient never knows what they did not see.

Why is the score so consistent across very different organizations?

Because almost no one has built for this channel yet, and the things that create traditional advantage do not carry over to it.

A large academic medical center has enormous advantages in the old model: brand recognition, referral networks, decades of reputation, and a big marketing budget. None of those are signals an AI engine reads when it assembles an answer. The model reads structured data, content depth, and how clearly a page answers the specific question asked. On those dimensions, the big system and the small practice often start from the same place, which is close to zero. The academic center's service line pages are frequently just as thin and just as unstructured as the community hospital's. So the scores converge.

This is why the distribution is flat. The channel is new enough that incumbency confers almost no advantage. Everyone is roughly equally unprepared, which is a very different situation from being behind a competitor who has already figured it out.

Why uniform mediocrity is the opportunity, not the problem

When a whole field clusters at 4.4, the instinct is to feel reassured. If everyone is mediocre, no one is losing. That reading is exactly backward.

A flat distribution means there is no entrenched leader to dislodge. In the old search era, the national brands spent fifteen years building authority that a regional system could not realistically overtake. In AI visibility, that authority does not exist yet in most markets. The answer to the generic patient question is still up for grabs. The first organization in a market to do the structural work, deploy a real medical schema, build content that answers early patient-journey questions, and consolidate its digital architecture can become the cited answer while competitors are still assuming their reputation has it covered.

That window does not stay open. The moment one system in a market starts compounding its AI visibility, the cost of catching up rises sharply, just as it did with traditional search. The 4.4 average is the sound of a starting gun, not an all-clear.

Why your peer benchmark is lying to you

Most organizations benchmark against a peer set: systems of similar size, prestige, or region. That is a reasonable instinct and, in this case, a dangerous one. If every organization in your peer set is sitting at a 4.4, comparing yourself to them tells you nothing except that you are all equally exposed.

The benchmark that matters is absolute, not relative. The question is not how I compare to systems like me. How often does an AI engine actually cite me when a patient in my market asks the question that precedes choosing a provider? Measured against that standard, a 4.4 is not a passing grade on a curve. It is the distance between where you are and where patient discovery now happens. A field grading itself on its own curve is how an entire industry stays at 4.4 for years without alarm.

What to do about a 4.4

First, get your real number and use it in the generic queries, not your brand name. A branded search will flatter you. The score that predicts growth comes from the questions patients ask before they know who you are.

Second, treat the gap as structural work, because that is what it is. The five dimensions that drive the score are buildable: structured data on service line pages, content depth that answers the questions that sit earliest in the patient journey, a digital front door that converts the visit, clean data integration, and governance so the work holds. None of this is an advertising war. It is the unglamorous infrastructure most organizations have never funded, which is precisely why doing it now creates separation.

Third, move before your market does. The 4.4 is uniform today. It will not be uniform for long. The organizations that act while the field is still flat will own the answer in their markets, the way two national brands own it in traditional search today. The ones that wait will be buying back visibility at a much higher price, if they can buy it back at all.

FAQs

What is a good AI readiness score for a health system?

Against the current benchmark, anything above the 4.4 mean is above average, but average is the wrong target. Because the whole field is clustered low, the meaningful goal is absolute: consistently being cited when patients ask generic, non-branded questions that drive new-patient volume. A score in the 7 to 8 range reflects an organization that has done the structural work most have not.

Why is my large health system scoring the same as small practices?

Because AI engines weigh digital structure rather than brand size or reputation. The advantages that make a large system dominant in traditional channels, recognition, referral networks, and budget, are not signals AI reads. On the structural signals AI does read, large systems and small practices often start from the same low baseline.

Is a 4.4 industry average good news or bad news?

Both, depending on timing. It is bad news because it means most organizations are invisible in most relevant AI searches. It is good news because it means no competitor has built a durable lead yet, so the first mover in a market can separate quickly. The window is open now and will close as organizations begin to compound visibility.

Should we benchmark our AI visibility against our peers?

Not primarily. If your entire peer set is underperforming, a relative comparison hides the real gap. Benchmark absolutely instead: how often AI actually cites you when a patient is looking. Peer comparison is a useful context, but it should never be the standard you grade yourself against.

How do we raise our AI readiness score?

Do the structural work across the five dimensions: deploy medical schema, build content that answers early patient-journey questions, strengthen the digital front door, integrate your data, and put governance in place so it holds. It is infrastructure work, not a larger ad budget, and most organizations have never done it.

Get Your Number

The AI Health Strategist National AI Visibility Benchmark Study documents the full distribution behind the 4.4 average.

To request it, or to schedule a complimentary AI Readiness Scan for your flagship service line, email jeff.montgomery@aihealthstrategist.com or info@aihealthstrategist.com.

‍